US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Roivant Sciences Ltd.

10.15

+0.13001.30%

Post-market: 10.150.00000.00%16:25 EDT

Volume:2.62M

Turnover:26.61M

Market Cap:7.24B

PE:-65.20

High:10.22

Open:10.05

Low:10.01

Close:10.02

Loading ...

Overview Company News Filings

Roivant Sciences Ltd - Kinevant to Discontinue Namilumab Development for Sarcoidosis

THOMSON REUTERS

Roivant Sciences Ltd - Namilumab Fails to Meet Primary Endpoint in Phase 2 Study

THOMSON REUTERS

Roivant Sciences Ltd - Secondary Endpoints Also Fail to Show Treatment Benefit

THOMSON REUTERS

Musk, Ramaswamy plan to lean on Supreme Court rulings to reduce federal agencies reach

JPMorgan’s ‘Analyst Focus List’ – growth, income, value, short ideas

Roivant Sciences' (NASDAQ:ROIV) Shareholders Should Assess Earnings With Caution

Simply Wall St.

Defense Stocks Don't Have to Fear Elon Musk, Pete Hegseth, and the $600 Hammer -- Barrons.com

Roivant Sciences Price Target Maintained With a $18.00/Share by HC Wainwright & Co.

TD Cowen Keeps Their Buy Rating on Roivant Sciences (ROIV)

Roivant Sciences Ltd reports results for the quarter ended September 30 - Earnings Summary

Roivant Sciences' Fiscal Q2 Net Loss Narrows, Revenue Rises

MT Newswires Live

Roivant Sciences Q2 2025 GAAP EPS $(0.31) Misses $(0.26) Estimate

Roivant Reports Financial Results for the Second Quarter Ended September 30, 2024, and Provides Business Update

Roivant Sciences (ROIV) Receives a Buy from TD Cowen

Organon: FDA Extends Vtama Atopic-Dermatitis Review to March

Roivant to Report Financial Results for the Second Quarter Ended September 30, 2024 and Provide Business Update on Tuesday, November 12, 2024

THOMSON REUTERS

Roivant to Report Financial Results for the Second Quarter Ended September 30, 2024 and Provide Business Update on Tuesday, November 12, 2024

Organon Finalizes Acquisition of Dermavant From Roivant

MT Newswires Live

Organon completes acquisition of Dermavant

Press Release: Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA(R) (tapinarof) Cream, 1%

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ROIV/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"ROIV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ROIV\",,,,,undefined,":{"symbol":"ROIV","market":"US","secType":"STK","nameCN":"Roivant Sciences Ltd.","latestPrice":10.15,"timestamp":1744920000000,"preClose":10.02,"halted":0,"volume":2621846,"hourTrading":{"tag":"盘后","latestPrice":10.15,"preClose":10.15,"latestTime":"16:25 EDT","volume":86182,"amount":874745.86,"timestamp":1744921542063},"delay":0,"floatShares":370552084,"shares":713549458,"eps":-0.155667,"marketStatus":"Market Closed","change":0.13,"latestTime":"04-17 16:00:00 EDT","open":10.05,"high":10.219,"low":10.01,"amount":26606364.639989,"amplitude":0.020858,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.155667,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"listingDate":1607403600000,"exchange":"NASDAQ","adjPreClose":10.02,"preHourTrading":{"tag":"盘前","latestPrice":10.08,"preClose":10.02,"latestTime":"09:29 EDT","volume":1674,"amount":16873.920000000002,"timestamp":1744896599999},"postHourTrading":{"tag":"盘后","latestPrice":10.15,"preClose":10.15,"latestTime":"16:25 EDT","volume":86182,"amount":874745.86,"timestamp":1744921542063},"volumeRatio":0.3971480489691445,"impliedVol":0.3401,"impliedVolPercentile":0.6813},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ROIV\",,,,,undefined,":{"symbol":"ROIV","floatShares":370552084,"roa":"-11.62%","roe":"-14.64%","lyrEps":5.552418,"volumeRatio":0.3971480489691445,"shares":713549458,"dividePrice":0,"high":10.219,"amplitude":0.020858,"preClose":10.02,"low":10.01,"week52Low":8.73,"pbRate":"1.40","psRate":"59.08","week52High":13.055,"institutionHeld":0,"latestPrice":10.15,"eps":-0.155667,"divideRate":0,"volume":2621846,"delay":0,"ttmEps":-0.155667,"open":10.05,"prevYearClose":11.83,"prevWeekClose":9.86,"prevMonthClose":10.09,"prevQuarterClose":10.09,"fiveDayClose":9.65,"twentyDayClose":10.97,"sixtyDayClose":11.16},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ROIV\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2488915708","title":"Roivant Sciences Ltd - Kinevant to Discontinue Namilumab Development for Sarcoidosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2488915708","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488915708?lang=en_us&edition=fundamental","pubTime":"2024-12-03 20:00","pubTimestamp":1733227201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nTUA535PPQ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","ROIV"],"gpt_icon":0},{"id":"2488915704","title":"Roivant Sciences Ltd - Namilumab Fails to Meet Primary Endpoint in Phase 2 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2488915704","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488915704?lang=en_us&edition=fundamental","pubTime":"2024-12-03 20:00","pubTimestamp":1733227201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nTUA535PPQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ROIV","BK4139"],"gpt_icon":0},{"id":"2488150409","title":"Roivant Sciences Ltd - Secondary Endpoints Also Fail to Show Treatment Benefit","url":"https://stock-news.laohu8.com/highlight/detail?id=2488150409","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488150409?lang=en_us&edition=fundamental","pubTime":"2024-12-03 20:00","pubTimestamp":1733227201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nTUA535PPQ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ROIV","BK4007","BK4139"],"gpt_icon":0},{"id":"2485126771","title":"Musk, Ramaswamy plan to lean on Supreme Court rulings to reduce federal agencies reach","url":"https://stock-news.laohu8.com/highlight/detail?id=2485126771","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485126771?lang=en_us&edition=fundamental","pubTime":"2024-11-21 02:46","pubTimestamp":1732128362,"startTime":"0","endTime":"0","summary":"Nov 20 (Reuters) - Elon Musk's government efficiency panel said in a Wall Street Journal opinion story on Wednesday that they will apply recent Supreme Court rulings that can be used to take power awa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234570918.USD","LU1435385759.SGD","LU2602419157.SGD","LU1861215975.USD","LU1861558580.USD","LU1914381329.SGD","BK4555","LU0198837287.USD","LU0316494557.USD","LU0719512351.SGD","SG9999015978.USD","LU0097036916.USD","LU2087621335.USD","BK4592","BK4516","BK4527","LU1720051017.SGD","LU2249611893.SGD","BK4598","LU2756315664.SGD","LU2213496289.HKD","BK4588","LU0689472784.USD","LU1429558221.USD","SG9999015945.SGD","LU0820561818.USD","LU2756315318.SGD","BK4007","LU0823414478.USD","LU1852331112.SGD","LU2326559502.SGD","LU0234572021.USD","SG9999015952.SGD","TSLA","IE00BSNM7G36.USD","LU0943347566.SGD","LU0082616367.USD","LU2023250330.USD","BK4581","BK4533","LU0823411888.USD","LU0820561909.HKD","BK4139","IE00BJLML261.HKD","LU1551013425.SGD","LU1861559042.SGD","BK4548","LU1145028129.USD","ROIV","LU1629891620.HKD"],"gpt_icon":1},{"id":"2484924507","title":"JPMorgan’s ‘Analyst Focus List’ – growth, income, value, short ideas","url":"https://stock-news.laohu8.com/highlight/detail?id=2484924507","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484924507?lang=en_us&edition=fundamental","pubTime":"2024-11-20 00:06","pubTimestamp":1732032406,"startTime":"0","endTime":"0","summary":"Sean Anthony Eddy/E+ via Getty Images J.P. Morgan analysts updated their “Analyst Focus List,” adding Tapestry (TPR), Alarm.com (ALRM), Regency Centers (REG), and Travere (TVTX). This is a list of sto","market":"hk","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1706156497/image_1706156497.jpg?io=getty-c-w750","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1706156497/image_1706156497.jpg?io=getty-c-w750"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4307534-jpmorgans-analyst-focus-list-growth-income-value-short-ideas","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["TRGP","REG.AU","ULTA","ELF","ALL","AXL.AU","NOW","AGCO","BSX","ACI","AXL","TMUS","BBY","TJX","JPM","PVH","TRU.AU","PODD","VST","LLY","T","XENE","DD","EWTX","TFII","RCL.AU","TMO","ANF","ARMK","TVTX","CZR.AU","CYBR","BRBR","LOW","AMZN","SPGI","GM","ALRM","TRU","ROIV","GWRE","LNG","NLY","PHM","SCHW","UAL","CAT","CAT.AU","NTRA"],"gpt_icon":1},{"id":"2484091797","title":"Roivant Sciences' (NASDAQ:ROIV) Shareholders Should Assess Earnings With Caution","url":"https://stock-news.laohu8.com/highlight/detail?id=2484091797","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484091797?lang=en_us&edition=fundamental","pubTime":"2024-11-19 19:05","pubTimestamp":1732014353,"startTime":"0","endTime":"0","summary":"The latest earnings release from Roivant Sciences Ltd.  disappointed investors. We did some analysis and believe that they might be concerned about some weak underlying factors.Check out our latest analysis for Roivant Sciences. NasdaqGS:ROIV Earnings and Revenue History November 19th 2024. Given the accrual ratio, it's not overly surprising that Roivant Sciences' profit was boosted by unusual items worth US$5.5b in the last twelve months. While we like to see profit increases, we tend to be a little more cautious when unusual items have made a big contribution. When we crunched the numbers on thousands of publicly listed companies, we found that a boost from unusual items in a given year is often not repeated the next year. Which is hardly surprising, given the name. Roivant Sciences had a rather significant contribution from unusual items relative to its profit to September 2024. As","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/H9sVDVM9mi9ws1HvXhxW7w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/H9sVDVM9mi9ws1HvXhxW7w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/roivant-sciences-nasdaq-roiv-shareholders-110553273.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":[".IXIC","NDAQ","ROIV"],"gpt_icon":0},{"id":"2483056543","title":"Defense Stocks Don't Have to Fear Elon Musk, Pete Hegseth, and the $600 Hammer -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2483056543","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483056543?lang=en_us&edition=fundamental","pubTime":"2024-11-15 23:44","pubTimestamp":1731685440,"startTime":"0","endTime":"0","summary":"Investors are wondering what is next for defense stocks after a swift two-day decline triggered by rising uncertainty.Three things are weighing on investors' minds. For starters, Tuesday's nomination of Pete Hegseth as defense secretary surprised Wall Street. That was followed by a Thursday report from Reuters that indicated the coming Trump administration plans significant turnover at the Defense Department.Topping things off is the newly created Department of Government Efficiency, headed by Tesla CEO Elon Musk and Roivant Sciences founder Vivek Ramaswamy. They are tasked with reducing wasteful government spending, and no one knows how that will affect the defense sector.It was a lot for investors to digest in a short time. Shares of large defense contractors Lockheed Martin, General Dynamics, Northrop Grumman, and L3Harris Technologies fell 5.5% on average between Tuesday and Thursday. The iShares Aerospace & Defense ETF fell 1.9%.\"The period 2010 to 2013 is likely the timeframe mos","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LHX","LMT","LU1244550577.SGD","LU1162221912.USD","BK4564","BK4516","LU1244550221.USD","IE00BFXG1179.USD","BK4139","LU1435385759.SGD","LU0320765646.SGD","BK4551","LU1244550494.USD","BK4585","BK4187","LU2326559502.SGD","BA","BK4007","ROIV","BK4588","LU1429558221.USD"],"gpt_icon":1},{"id":"2483569748","title":"Roivant Sciences Price Target Maintained With a $18.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2483569748","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483569748?lang=en_us&edition=fundamental","pubTime":"2024-11-14 03:10","pubTimestamp":1731525000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ROIV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 13, 2024 14:10 ET (19:10 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV"],"gpt_icon":0},{"id":"2483924093","title":"TD Cowen Keeps Their Buy Rating on Roivant Sciences (ROIV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2483924093","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483924093?lang=en_us&edition=fundamental","pubTime":"2024-11-13 08:15","pubTimestamp":1731456927,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Yaron Werber maintained a Buy rating on Roivant Sciences (ROIV – Research Report) yesterday. The company’s shares closed yesterday...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/td-cowen-keeps-their-buy-rating-on-roivant-sciences-roiv-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/td-cowen-keeps-their-buy-rating-on-roivant-sciences-roiv-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ROIV","TD","COWN"],"gpt_icon":0},{"id":"2482707371","title":"Roivant Sciences Ltd reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2482707371","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482707371?lang=en_us&edition=fundamental","pubTime":"2024-11-12 21:38","pubTimestamp":1731418734,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd reports results for the quarter ended September 30 - Earnings SummaryRoivant Sciences Ltd ROIV.OQ reported a quarterly adjusted loss of 31 cents per share for the quarter ended Se","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nL8N3MJ1I1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV"],"gpt_icon":0},{"id":"2482470648","title":"Roivant Sciences' Fiscal Q2 Net Loss Narrows, Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2482470648","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482470648?lang=en_us&edition=fundamental","pubTime":"2024-11-12 20:45","pubTimestamp":1731415518,"startTime":"0","endTime":"0","summary":"Roivant Sciences  reported a fiscal Q2 net loss Tuesday of $0.31 per diluted share, narrowing from a loss of $0.40 a year earlier.Analysts polled by Capital IQ expected a loss of $0.27.Net revenue for the quarter ended Sept. 30 was $4.5 million, up from $3.6 million a year earlier.Analysts surveyed by Capital IQ expected $45.9 million.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ROIV"],"gpt_icon":0},{"id":"2482570550","title":"Roivant Sciences Q2 2025 GAAP EPS $(0.31) Misses $(0.26) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2482570550","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482570550?lang=en_us&edition=fundamental","pubTime":"2024-11-12 20:29","pubTimestamp":1731414585,"startTime":"0","endTime":"0","summary":"Roivant Sciences (NASDAQ:ROIV) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.26) by 19.23 percent.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41897449/roivant-sciences-q2-2025-gaap-eps-0-31-misses-0-26-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Roivant Sciences Q2 2025 GAAP EPS $(0.31) Misses $(0.26) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV"],"gpt_icon":0},{"id":"2482038187","title":"Roivant Reports Financial Results for the Second Quarter Ended September 30, 2024, and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2482038187","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482038187?lang=en_us&edition=fundamental","pubTime":"2024-11-12 20:00","pubTimestamp":1731412800,"startTime":"0","endTime":"0","summary":"BASEL, Switzerland and LONDON and NEW YORK, Nov. 12, 2024  -- Roivant  today reported its financial results for the second quarter ended September 30, 2024, and provided a business update.Brepocitinib 52-week data from the Phase 2 NEPTUNE study in non-infectious uveitis  showed potential best-in-indication efficacy sustained to one year; first patients enrolled in Phase 3 NIU program. IMVT-1402 cleared five Investigational New Drug  applications across a range of therapeutic areas and FDA divisions, including the potentially registrational trial for difficult-to-treat rheumatoid arthritis  expected to initiate by March 31, 2025. Batoclimab proof of concept data in Graves’ disease  demonstrate potential of deeper IgG reduction with potent FcRn inhibition to transform treatment for GD patients who are not well controlled on antithyroid drugs ; initiation of potentially registrational trial to evaluate IMVT-1402 in GD expected by year end. Roivant continued to return capital through share","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/R35Zaer8vgFzoWKpttvTXg--~B/aD00MDA7dz0xNzI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/96e32f55c54dad2fb7c9058f4f7181f9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/R35Zaer8vgFzoWKpttvTXg--~B/aD00MDA7dz0xNzI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/96e32f55c54dad2fb7c9058f4f7181f9"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/roivant-reports-financial-results-second-120000604.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4516","LU0208291251.USD","BK4585","BK4139","BK4161","BK4558","BK4007","LU0417517546.SGD","LU0256863811.USD","BK4555","LU1989772923.USD","ROIV","LU1989772840.SGD","LU0320765489.SGD","BK4550","BK4566","PH","NIU","LU0170899867.USD","LU0211331839.USD","BK4091","GD","LU0070302665.USD","LU0256863902.USD","BK4187","BK4580","BK4588"],"gpt_icon":1},{"id":"2481510894","title":"Roivant Sciences (ROIV) Receives a Buy from TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2481510894","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481510894?lang=en_us&edition=fundamental","pubTime":"2024-11-08 21:31","pubTimestamp":1731072713,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Yaron Werber maintained a Buy rating on Roivant Sciences (ROIV – Research Report) today. The company’s shares closed yesterday at ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/roivant-sciences-roiv-receives-a-buy-from-td-cowen-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/roivant-sciences-roiv-receives-a-buy-from-td-cowen-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4585","BK4207","BK4127","COWN","TD","BK4566","ROIV","BK4139"],"gpt_icon":0},{"id":"2481250656","title":"Organon: FDA Extends Vtama Atopic-Dermatitis Review to March","url":"https://stock-news.laohu8.com/highlight/detail?id=2481250656","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481250656?lang=en_us&edition=fundamental","pubTime":"2024-11-05 21:00","pubTimestamp":1730811600,"startTime":"0","endTime":"0","summary":"Organon said the Food and Drug Administration extended by three months its review of an application seeking expanded approval of the healthcare company's recently acquired skin-care cream Vtama.Organon, which is seeking approval of Vtama as a treatment for atopic dermatitis, said the FDA set a new target action date of March 12 for a decision after requesting the final datasets and clinical-study report from a long-term extension study.The Jersey City, N.J., company picked up Vtama as part of its acquisition of Dermavant Sciences from Roivant Sciences last month and had been expecting a green light in atopic dermatitis by the end of the year.Organon noted that the FDA, which approved Vtama as a treatment for plaque psoriasis in 2022, hasn't raised any concerns regarding the safety and efficacy of Vtama or any concerns regarding the approvability of the new indication.Organon said that as a result of the delay, it now expects Vtama to contribute about $125 million in revenue next year, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065169927.USD","LU2065171402.SGD","BK4559","BK4588","BK4585","LU2065170008.USD","ROIV","LU2065171311.SGD","BK4007","BK4139","OGN"],"gpt_icon":0},{"id":"2479155252","title":"Roivant to Report Financial Results for the Second Quarter Ended September 30, 2024 and Provide Business Update on Tuesday, November 12, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2479155252","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479155252?lang=en_us&edition=fundamental","pubTime":"2024-10-30 04:35","pubTimestamp":1730234100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241029:nTUA4HL26J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ROIV","BK4007","BK4139"],"gpt_icon":0},{"id":"2479257540","title":"Roivant to Report Financial Results for the Second Quarter Ended September 30, 2024 and Provide Business Update on Tuesday, November 12, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2479257540","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479257540?lang=en_us&edition=fundamental","pubTime":"2024-10-30 04:35","pubTimestamp":1730234100,"startTime":"0","endTime":"0","summary":"BASEL, Switzerland and LONDON and NEW YORK, Oct. 29, 2024  -- Roivant  today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, November 12, 2024, to report its financial results for the second quarter ended September 30, 2024, and provide a business update.Our forward-looking statements include, but are not limited to, statements regarding our or our management team’s expectations, hopes, beliefs, intentions or strategies regarding the future, and statements that are not historical facts, including statements about potential share repurchase","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/R35Zaer8vgFzoWKpttvTXg--~B/aD00MDA7dz0xNzI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/96e32f55c54dad2fb7c9058f4f7181f9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/R35Zaer8vgFzoWKpttvTXg--~B/aD00MDA7dz0xNzI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/96e32f55c54dad2fb7c9058f4f7181f9"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/roivant-report-financial-results-second-203500707.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ROIV","BK4007","BK4139"],"gpt_icon":0},{"id":"2478861864","title":"Organon Finalizes Acquisition of Dermavant From Roivant","url":"https://stock-news.laohu8.com/highlight/detail?id=2478861864","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478861864?lang=en_us&edition=fundamental","pubTime":"2024-10-28 21:44","pubTimestamp":1730123047,"startTime":"0","endTime":"0","summary":"Organon  said Monday it finalized the acquisition of Dermavant Sciences from Roivant .Dermavant develops and commercializes treatments in the immuno-dermatology space, including Vtama, which was approved by the US Food and Drug Administration to treat plaque psoriasis in adults, Organon said.Price: 17.37, Change: +0.21, Percent Change: +1.22","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ROIV","LU2065171311.SGD","BK4139","BK4585","LU2065171402.SGD","LU2065170008.USD","OGN","BK4007","BK4559","BK4588","LU2065169927.USD"],"gpt_icon":0},{"id":"2478248529","title":"Organon completes acquisition of Dermavant","url":"https://stock-news.laohu8.com/highlight/detail?id=2478248529","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478248529?lang=en_us&edition=fundamental","pubTime":"2024-10-28 21:30","pubTimestamp":1730122259,"startTime":"0","endTime":"0","summary":"Organon (OGN) announced completion of its acquisition of Dermavant Sciencesfrom Roivant (ROIV). Dermavant is a company dedicated to developing and ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/organon-completes-acquisition-of-dermavant?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/organon-completes-acquisition-of-dermavant?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065170008.USD","BK4559","LU2065171402.SGD","BK4139","LU2065171311.SGD","BK4585","ROIV","BK4007","LU2065169927.USD","BK4588","OGN"],"gpt_icon":0},{"id":"2478485595","title":"Press Release: Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA(R) (tapinarof) Cream, 1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478485595","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478485595?lang=en_us&edition=fundamental","pubTime":"2024-10-28 21:25","pubTimestamp":1730121900,"startTime":"0","endTime":"0","summary":"Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA  Cream, 1%. The acquisition expands Organon's dermatology capabilities with a nonbiologic, non-steroidal topical treatment in the U.S.\"I would like to thank Kevin and the entire Organon team for their partnership in the acquisition of Dermavant,\" said Mayukh Sukhatme, MD, President and Chief Investment Officer of Roivant. \"This deal represents a true win-win outcome for Organon and Roivant in our mutual goal to address patient needs and is emblematic of Roivant's ability to form non-traditional, value-enhancing collaborations on important medicines. We believe that Organon's strong global commercial footprint will maximize the impact of VTAMA for patients globally, and we are excited to continue to share meaningfully in the success of VTA","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2065171311.SGD","BK4022","ROIV","LU2065170008.USD","BK4007","BK4585","BK4232","LU2065169927.USD","BK4139","R","BK4559","LU2065171402.SGD","OGN"],"gpt_icon":1}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":61,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ROIV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-10","symbol":"ROIV","fiscalQuarterEnding":"2024/12","expectedEps":-0.3,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739163600000,"reportTimeType":"pre","actualEps":-0.2},{"market":"US","date":"2024-11-12","symbol":"ROIV","fiscalQuarterEnding":"2024/09","expectedEps":-0.27,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.37},{"market":"US","date":"2024-08-08","symbol":"ROIV","fiscalQuarterEnding":"2024/06","expectedEps":-0.27,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-0.24},{"market":"US","date":"2024-05-30","symbol":"ROIV","fiscalQuarterEnding":"2024/03","expectedEps":-0.31,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1717041600000,"reportTimeType":"pre","actualEps":-0.28},{"market":"US","date":"2024-02-13","symbol":"ROIV","fiscalQuarterEnding":"2023/12","expectedEps":-0.33,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1707800400000,"reportTimeType":"pre","actualEps":-0.26}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ROIV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ROIV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.5,"hold":0.1,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":10,"updateTime":1707969600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ROIV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ROIV","date":"2025-04-17","current":-61.307702,"percent":0.048089,"low":-67.975517,"twenty":-7.029605,"median":-3.656118,"eighty":1.795452,"high":2.128992,"avg":-6.558432,"sd":14.743544,"marketCap":7149765569},"quantilePoints":[{"date":"2021-10-01","current":-7.393592,"twenty":-7.393592,"median":-7.393592,"eighty":-7.393592,"marketCap":6566796009},{"date":"2021-10-08","current":-5.068762,"twenty":-7.200647,"median":-5.392973,"eighty":-5.011828,"marketCap":4501942504},{"date":"2021-10-15","current":-4.760366,"twenty":-6.226432,"median":-5.064808,"eighty":-4.897958,"marketCap":4228033366},{"date":"2021-10-22","current":-5.377158,"twenty":-5.411951,"median":-4.997594,"eighty":-4.833116,"marketCap":4775851643},{"date":"2021-10-29","current":-6.278622,"twenty":-6.291275,"median":-5.22296,"eighty":-4.848931,"marketCap":5576509124},{"date":"2021-11-05","current":-6.120471,"twenty":-6.278622,"median":-5.416696,"eighty":-4.897958,"marketCap":5436042899},{"date":"2021-11-12","current":-6.642371,"twenty":-6.291275,"median":-5.970226,"eighty":-4.945404,"marketCap":5899581441},{"date":"2021-11-19","current":-5.294334,"twenty":-6.278622,"median":-5.426692,"eighty":-4.965964,"marketCap":5618648992},{"date":"2021-11-26","current":-4.632542,"twenty":-6.278622,"median":-5.392973,"eighty":-4.942241,"marketCap":4916317868},{"date":"2021-12-03","current":-5.94289,"twenty":-6.246992,"median":-5.404834,"eighty":-4.886887,"marketCap":6306933493},{"date":"2021-12-10","current":-5.9098,"twenty":-6.278622,"median":-5.56694,"eighty":-4.942241,"marketCap":6271816937},{"date":"2021-12-17","current":-7.24662,"twenty":-6.278622,"median":-5.70859,"eighty":-4.958056,"marketCap":7690525807},{"date":"2021-12-23","current":-7.915029,"twenty":-6.461382,"median":-5.896565,"eighty":-4.962362,"marketCap":8399880243},{"date":"2021-12-31","current":-6.670861,"twenty":-6.679397,"median":-5.936272,"eighty":-4.990763,"marketCap":7079497729},{"date":"2022-01-07","current":-5.658319,"twenty":-6.654395,"median":-5.93348,"eighty":-5.048202,"marketCap":6004931110},{"date":"2022-01-14","current":-5.261244,"twenty":-6.643953,"median":-5.883329,"eighty":-5.051959,"marketCap":5583532435},{"date":"2022-01-21","current":-4.79799,"twenty":-6.611816,"median":-5.850239,"eighty":-4.961285,"marketCap":5091900649},{"date":"2022-01-28","current":-4.420769,"twenty":-6.571592,"median":-5.612629,"eighty":-4.867909,"marketCap":4691571908},{"date":"2022-02-04","current":-4.718575,"twenty":-6.480662,"median":-5.4664,"eighty":-4.79799,"marketCap":5007620914},{"date":"2022-02-11","current":-4.533273,"twenty":-6.411262,"median":-5.421694,"eighty":-4.75404,"marketCap":4810968199},{"date":"2022-02-18","current":-4.229896,"twenty":-6.336473,"median":-5.386985,"eighty":-4.697398,"marketCap":4588438579},{"date":"2022-02-25","current":-4.197996,"twenty":-6.294119,"median":-5.373749,"eighty":-4.638618,"marketCap":4553834970},{"date":"2022-03-04","current":-3.611042,"twenty":-6.287633,"median":-5.300952,"eighty":-4.614157,"marketCap":3917128561},{"date":"2022-03-11","current":-3.209106,"twenty":-6.278622,"median":-5.214919,"eighty":-4.599453,"marketCap":3481123085},{"date":"2022-03-18","current":-3.311185,"twenty":-6.26597,"median":-5.064808,"eighty":-4.551803,"marketCap":3591854634},{"date":"2022-03-25","current":-3.177207,"twenty":-6.224851,"median":-4.997594,"eighty":-4.245208,"marketCap":3446519476},{"date":"2022-04-01","current":-3.087888,"twenty":-6.188476,"median":-4.960747,"eighty":-4.132921,"marketCap":3349629370},{"date":"2022-04-08","current":-2.647672,"twenty":-6.180568,"median":-4.886887,"eighty":-3.804992,"marketCap":2872099563},{"date":"2022-04-14","current":-2.580683,"twenty":-6.166298,"median":-4.831534,"eighty":-3.511515,"marketCap":2799431984},{"date":"2022-04-22","current":-2.494554,"twenty":-6.126648,"median":-4.804608,"eighty":-3.330325,"marketCap":2706002239},{"date":"2022-04-29","current":-2.354195,"twenty":-6.120471,"median":-4.79799,"eighty":-3.283114,"marketCap":2553746358},{"date":"2022-05-06","current":-2.309536,"twenty":-6.09833,"median":-4.74149,"eighty":-3.183587,"marketCap":2505301306},{"date":"2022-05-13","current":-2.207457,"twenty":-5.999036,"median":-4.718575,"eighty":-3.099372,"marketCap":2394569756},{"date":"2022-05-20","current":-2.360575,"twenty":-5.953479,"median":-4.649087,"eighty":-2.763787,"marketCap":2560667080},{"date":"2022-05-27","current":-2.577493,"twenty":-5.941566,"median":-4.632542,"eighty":-2.637464,"marketCap":2795971623},{"date":"2022-06-03","current":-2.781651,"twenty":-5.936272,"median":-4.625924,"eighty":-2.634912,"marketCap":3017434722},{"date":"2022-06-10","current":-2.469034,"twenty":-5.930689,"median":-4.602882,"eighty":-2.583873,"marketCap":2678319352},{"date":"2022-06-17","current":-2.794411,"twenty":-5.9098,"median":-4.599453,"eighty":-2.577493,"marketCap":3031276165},{"date":"2022-06-24","current":-3.055988,"twenty":-5.888623,"median":-4.592835,"eighty":-2.577493,"marketCap":3315025761},{"date":"2022-07-01","current":-3.664409,"twenty":-5.883329,"median":-4.477021,"eighty":-2.580045,"marketCap":3097385357},{"date":"2022-07-08","current":-4.01261,"twenty":-5.863475,"median":-4.327927,"eighty":-2.582597,"marketCap":3391707043},{"date":"2022-07-15","current":-3.540051,"twenty":-5.794648,"median":-4.223516,"eighty":-2.595357,"marketCap":2992270469},{"date":"2022-07-22","current":-3.564922,"twenty":-5.698027,"median":-4.143766,"eighty":-2.610669,"marketCap":3013293447},{"date":"2022-07-29","current":-3.311167,"twenty":-5.603492,"median":-4.012978,"eighty":-2.627256,"marketCap":2798803556},{"date":"2022-08-05","current":-3.136457,"twenty":-5.546323,"median":-3.998124,"eighty":-2.642568,"marketCap":2651127991},{"date":"2022-08-12","current":-3.635628,"twenty":-5.492872,"median":-3.896543,"eighty":-2.647672,"marketCap":3073058176},{"date":"2022-08-19","current":-2.37779,"twenty":-5.442575,"median":-3.739024,"eighty":-2.627256,"marketCap":2603414024},{"date":"2022-08-26","current":-2.409923,"twenty":-5.426692,"median":-3.722442,"eighty":-2.582597,"marketCap":2638595295},{"date":"2022-09-02","current":-2.262114,"twenty":-5.420694,"median":-3.686206,"eighty":-2.571113,"marketCap":2476761450},{"date":"2022-09-09","current":-2.319952,"twenty":-5.407207,"median":-3.656118,"eighty":-2.54405,"marketCap":2540087737},{"date":"2022-09-16","current":-2.0886,"twenty":-5.390578,"median":-3.622956,"eighty":-2.522626,"marketCap":2286782589},{"date":"2022-09-23","current":-1.923582,"twenty":-5.383054,"median":-3.581602,"eighty":-2.479242,"marketCap":2106106321},{"date":"2022-09-30","current":-2.071549,"twenty":-5.375794,"median":-3.540051,"eighty":-2.458826,"marketCap":2268114499},{"date":"2022-10-07","current":-2.830689,"twenty":-5.36316,"median":-3.496169,"eighty":-2.456274,"marketCap":3099286894},{"date":"2022-10-14","current":-2.946489,"twenty":-5.331394,"median":-3.460918,"eighty":-2.458826,"marketCap":3226075903},{"date":"2022-10-21","current":-2.856422,"twenty":-5.302276,"median":-3.442407,"eighty":-2.462654,"marketCap":3127462229},{"date":"2022-10-28","current":-3.377526,"twenty":-5.281098,"median":-3.377526,"eighty":-2.464697,"marketCap":3698012771},{"date":"2022-11-04","current":-3.538361,"twenty":-5.242714,"median":-3.39361,"eighty":-2.46827,"marketCap":3874108617},{"date":"2022-11-11","current":-3.413882,"twenty":-5.212272,"median":-3.409693,"eighty":-2.479242,"marketCap":3737818266},{"date":"2022-11-18","current":-3.079035,"twenty":-5.152485,"median":-3.375884,"eighty":-2.494554,"marketCap":3627093935},{"date":"2022-11-25","current":-3.177564,"twenty":-5.06718,"median":-3.35355,"eighty":-2.494554,"marketCap":3743160940},{"date":"2022-12-02","current":-3.879584,"twenty":-5.051959,"median":-3.352764,"eighty":-2.499658,"marketCap":4570138358},{"date":"2022-12-09","current":-4.310649,"twenty":-5.012624,"median":-3.375884,"eighty":-2.52135,"marketCap":5077931509},{"date":"2022-12-16","current":-4.507707,"twenty":-4.994734,"median":-3.411571,"eighty":-2.52773,"marketCap":5310065520},{"date":"2022-12-23","current":-4.316807,"twenty":-4.979321,"median":-3.429759,"eighty":-2.532833,"marketCap":5085185696},{"date":"2022-12-30","current":-4.920298,"twenty":-4.963438,"median":-3.442407,"eighty":-2.532833,"marketCap":5796096108},{"date":"2023-01-06","current":-5.696215,"twenty":-4.986152,"median":-3.459421,"eighty":-2.537937,"marketCap":6710123779},{"date":"2023-01-13","current":-6.078015,"twenty":-5.062436,"median":-3.489823,"eighty":-2.548887,"marketCap":7159883427},{"date":"2023-01-20","current":-5.406785,"twenty":-5.233449,"median":-3.502516,"eighty":-2.555534,"marketCap":6369176949},{"date":"2023-01-27","current":-5.26515,"twenty":-5.262806,"median":-3.539206,"eighty":-2.566009,"marketCap":6202330628},{"date":"2023-02-03","current":-4.803295,"twenty":-5.259893,"median":-3.564922,"eighty":-2.571113,"marketCap":5658266538},{"date":"2023-02-10","current":-5.115464,"twenty":-5.244212,"median":-3.604662,"eighty":-2.574941,"marketCap":6026001052},{"date":"2023-02-17","current":-5.249117,"twenty":-5.262806,"median":-3.622956,"eighty":-2.577493,"marketCap":6537643757},{"date":"2023-02-24","current":-4.707155,"twenty":-5.260343,"median":-3.647828,"eighty":-2.578769,"marketCap":5862643415},{"date":"2023-03-03","current":-4.902017,"twenty":-5.255042,"median":-3.686206,"eighty":-2.581959,"marketCap":6105340167},{"date":"2023-03-10","current":-4.658439,"twenty":-5.243214,"median":-3.722442,"eighty":-2.58884,"marketCap":5801969227},{"date":"2023-03-17","current":-5.297833,"twenty":-5.243214,"median":-3.739024,"eighty":-2.598979,"marketCap":6598317945},{"date":"2023-03-24","current":-4.213908,"twenty":-5.243214,"median":-3.8468,"eighty":-2.606589,"marketCap":5248317262},{"date":"2023-03-31","current":-4.494023,"twenty":-5.232955,"median":-3.897301,"eighty":-2.613481,"marketCap":5597193843},{"date":"2023-04-06","current":-4.329608,"twenty":-5.228412,"median":-3.950432,"eighty":-2.619601,"marketCap":5392418458},{"date":"2023-04-14","current":-4.627992,"twenty":-5.217919,"median":-4.01261,"eighty":-2.637464,"marketCap":5764047860},{"date":"2023-04-21","current":-5.358727,"twenty":-5.233657,"median":-4.051523,"eighty":-2.647672,"marketCap":6674160680},{"date":"2023-04-28","current":-5.133417,"twenty":-5.258992,"median":-4.076932,"eighty":-2.647672,"marketCap":6393542560},{"date":"2023-05-05","current":-5.115149,"twenty":-5.249117,"median":-4.210756,"eighty":-2.654052,"marketCap":6370789740},{"date":"2023-05-12","current":-5.510964,"twenty":-5.261296,"median":-4.226706,"eighty":-2.654128,"marketCap":6863767517},{"date":"2023-05-19","current":-5.535322,"twenty":-5.302098,"median":-4.268175,"eighty":-2.724231,"marketCap":6894104611},{"date":"2023-05-26","current":-5.620574,"twenty":-5.32219,"median":-4.304491,"eighty":-2.730611,"marketCap":7000284440},{"date":"2023-05-31","current":-5.523143,"twenty":-5.32219,"median":-4.313728,"eighty":-2.730611,"marketCap":6878936064},{"date":"2023-06-09","current":-5.833705,"twenty":-5.36774,"median":-4.329608,"eighty":-2.730865,"marketCap":7265734013},{"date":"2023-06-16","current":-6.040747,"twenty":-5.386985,"median":-4.34784,"eighty":-2.731246,"marketCap":7523599312},{"date":"2023-06-23","current":-6.071194,"twenty":-5.402439,"median":-4.369153,"eighty":-2.743893,"marketCap":7561520679},{"date":"2023-06-30","current":-7.523496,"twenty":-5.414714,"median":-4.379957,"eighty":-2.752698,"marketCap":7591433186},{"date":"2023-07-07","current":-8.093458,"twenty":-5.42245,"median":-4.39535,"eighty":-2.763985,"marketCap":8166541761},{"date":"2023-07-10","current":-8.20745,"twenty":-5.426692,"median":-4.40302,"eighty":-2.769628,"marketCap":8281563476},{"date":"2023-07-21","current":-8.458233,"twenty":-5.426692,"median":-4.411894,"eighty":-2.775271,"marketCap":8534611249},{"date":"2023-07-28","current":-8.20745,"twenty":-5.456159,"median":-4.423904,"eighty":-2.776851,"marketCap":8281563476},{"date":"2023-08-02","current":-9.084475,"twenty":-5.504874,"median":-4.43381,"eighty":-2.779221,"marketCap":9166507826},{"date":"2023-08-11","current":-8.673275,"twenty":-5.533128,"median":-4.451397,"eighty":-2.781165,"marketCap":8751594647},{"date":"2023-08-17","current":-8.609097,"twenty":-5.568907,"median":-4.464601,"eighty":-2.789307,"marketCap":8342533149},{"date":"2023-08-25","current":-8.848017,"twenty":-5.635672,"median":-4.494023,"eighty":-2.794411,"marketCap":8574055808},{"date":"2023-09-01","current":-9.214361,"twenty":-5.70006,"median":-4.494023,"eighty":-2.796878,"marketCap":8929057219},{"date":"2023-09-08","current":-9.317894,"twenty":-5.725205,"median":-4.506954,"eighty":-2.804955,"marketCap":9029383704},{"date":"2023-09-15","current":-9.150649,"twenty":-5.757588,"median":-4.518382,"eighty":-2.830689,"marketCap":8867317843},{"date":"2023-09-19","current":-8.855981,"twenty":-5.782386,"median":-4.524471,"eighty":-2.831089,"marketCap":8581773230},{"date":"2023-10-05","current":-7.985677,"twenty":-5.795976,"median":-4.528872,"eighty":-2.831489,"marketCap":7738416687},{"date":"2023-10-09","current":-8.819584,"twenty":-5.801844,"median":-4.533273,"eighty":-2.83189,"marketCap":8546503125},{"date":"2023-11-10","current":-6.982171,"twenty":-5.878767,"median":-4.593193,"eighty":-2.839209,"marketCap":6765981641},{"date":"2023-11-17","current":-7.385988,"twenty":-5.911027,"median":-4.599453,"eighty":-2.843555,"marketCap":7251370631},{"date":"2023-11-24","current":-7.476061,"twenty":-5.936844,"median":-4.606312,"eighty":-2.848702,"marketCap":7339801980},{"date":"2023-12-01","current":-7.828164,"twenty":-5.955617,"median":-4.626958,"eighty":-2.858995,"marketCap":7685488163},{"date":"2023-12-08","current":-7.983745,"twenty":-6.044634,"median":-4.632542,"eighty":-2.865429,"marketCap":7838233221},{"date":"2023-12-15","current":-9.113752,"twenty":-6.115375,"median":-4.64756,"eighty":-2.880169,"marketCap":8947644692},{"date":"2023-12-22","current":-8.630633,"twenty":-6.163796,"median":-4.652396,"eighty":-2.903623,"marketCap":8473331092},{"date":"2023-12-29","current":-9.310275,"twenty":-6.191639,"median":-4.65697,"eighty":-2.914323,"marketCap":9140585817},{"date":"2024-01-05","current":-8.85991,"twenty":-6.278622,"median":-4.665632,"eighty":-2.914323,"marketCap":8698429071},{"date":"2024-01-12","current":-8.999114,"twenty":-6.411262,"median":-4.682797,"eighty":-2.933623,"marketCap":8835095702},{"date":"2024-01-19","current":-8.606068,"twenty":-6.622001,"median":-4.702881,"eighty":-2.951636,"marketCap":8449213451},{"date":"2024-01-26","current":-8.614256,"twenty":-6.787201,"median":-4.725193,"eighty":-2.964833,"marketCap":8457252665},{"date":"2024-02-02","current":-8.229399,"twenty":-7.069423,"median":-4.752459,"eighty":-2.973569,"marketCap":8079409627},{"date":"2024-02-09","current":-8.655198,"twenty":-7.254542,"median":-4.792407,"eighty":-2.978932,"marketCap":8497448732},{"date":"2024-02-16","current":2.065844,"twenty":-7.303922,"median":-4.780228,"eighty":-2.964833,"marketCap":9226936768},{"date":"2024-02-23","current":2.049606,"twenty":-7.257183,"median":-4.752459,"eighty":-2.914323,"marketCap":9154410628},{"date":"2024-03-01","current":2.06404,"twenty":-7.238464,"median":-4.725193,"eighty":-2.857709,"marketCap":9218878308},{"date":"2024-03-08","current":2.011717,"twenty":-7.203572,"median":-4.702881,"eighty":-2.831089,"marketCap":8985182966},{"date":"2024-03-15","current":1.845728,"twenty":-7.17056,"median":-4.682797,"eighty":-2.784203,"marketCap":8243804641},{"date":"2024-03-22","current":1.851141,"twenty":-7.072124,"median":-4.662035,"eighty":-2.734408,"marketCap":8267980021},{"date":"2024-03-28","current":1.955786,"twenty":-7.061318,"median":-4.653949,"eighty":-2.724231,"marketCap":8735370705},{"date":"2024-04-05","current":2.07667,"twenty":-7.041464,"median":-4.649343,"eighty":-2.647672,"marketCap":9275287529},{"date":"2024-04-12","current":2.015326,"twenty":-6.982171,"median":-4.633193,"eighty":-2.603013,"marketCap":9001299887},{"date":"2024-04-19","current":1.869183,"twenty":-6.836309,"median":-4.627992,"eighty":-2.577493,"marketCap":8348564622},{"date":"2024-04-26","current":1.963003,"twenty":-6.71354,"median":-4.606312,"eighty":-2.558353,"marketCap":8767604545},{"date":"2024-05-03","current":2.027955,"twenty":-6.670861,"median":-4.599453,"eighty":-2.532833,"marketCap":9057709107},{"date":"2024-05-10","current":2.02976,"twenty":-6.650279,"median":-4.593193,"eighty":-2.494554,"marketCap":9065767567},{"date":"2024-05-17","current":2.058627,"twenty":-6.642371,"median":-4.533273,"eighty":-2.462654,"marketCap":9194702928},{"date":"2024-05-24","current":1.973829,"twenty":-6.591446,"median":-4.51,"eighty":-2.454908,"marketCap":8815955305},{"date":"2024-05-31","current":1.718448,"twenty":-6.564974,"median":-4.500113,"eighty":-2.434582,"marketCap":7675319574},{"date":"2024-06-07","current":1.803946,"twenty":-6.454764,"median":-4.494023,"eighty":-2.405157,"marketCap":7845225590},{"date":"2024-06-14","current":1.83622,"twenty":-6.411262,"median":-4.475755,"eighty":-2.37522,"marketCap":7985582733},{"date":"2024-06-21","current":1.834521,"twenty":-6.357491,"median":-4.458443,"eighty":-2.36232,"marketCap":7978195515},{"date":"2024-06-28","current":1.795452,"twenty":-6.315456,"median":-4.451397,"eighty":-2.359299,"marketCap":7808289499},{"date":"2024-07-05","current":1.780165,"twenty":-6.293959,"median":-4.43381,"eighty":-2.336521,"marketCap":7741804537},{"date":"2024-07-12","current":1.909261,"twenty":-6.284629,"median":-4.411894,"eighty":-2.31496,"marketCap":8303233110},{"date":"2024-07-15","current":1.927946,"twenty":-6.281626,"median":-4.40302,"eighty":-2.312728,"marketCap":8384492509},{"date":"2024-08-02","current":1.805074,"twenty":-6.278622,"median":-4.39535,"eighty":-2.309536,"marketCap":7850132402},{"date":"2024-08-09","current":1.693429,"twenty":-6.278622,"median":-4.366072,"eighty":-2.252116,"marketCap":8020144685},{"date":"2024-08-16","current":1.766031,"twenty":-6.246992,"median":-4.329608,"eighty":-2.236408,"marketCap":8363991829},{"date":"2024-08-23","current":1.823806,"twenty":-6.191639,"median":-4.316807,"eighty":-2.107879,"marketCap":8637614904},{"date":"2024-08-30","current":1.876896,"twenty":-6.183731,"median":-4.292175,"eighty":-2.071549,"marketCap":8889052324},{"date":"2024-09-06","current":1.903441,"twenty":-6.177405,"median":-4.262355,"eighty":-2.013004,"marketCap":9014771034},{"date":"2024-09-13","current":1.892511,"twenty":-6.151768,"median":-4.223516,"eighty":-1.918435,"marketCap":8963004506},{"date":"2024-09-20","current":1.861281,"twenty":-6.131704,"median":-4.204376,"eighty":1.697441,"marketCap":8815100142},{"date":"2024-09-27","current":1.806629,"twenty":-6.122015,"median":-4.064326,"eighty":1.738237,"marketCap":8556267503},{"date":"2024-10-04","current":1.750416,"twenty":-6.120471,"median":-4.028928,"eighty":1.751704,"marketCap":8290039647},{"date":"2024-10-11","current":1.853474,"twenty":-6.110279,"median":-4.000218,"eighty":1.762284,"marketCap":8778124050},{"date":"2024-10-18","current":1.85972,"twenty":-6.083958,"median":-3.901446,"eighty":1.777262,"marketCap":8807704923},{"date":"2024-10-25","current":1.842543,"twenty":-6.072558,"median":-3.879584,"eighty":1.781575,"marketCap":8726357523},{"date":"2024-10-31","current":1.83942,"twenty":-6.056813,"median":-3.805687,"eighty":1.791991,"marketCap":8711567086},{"date":"2024-11-08","current":1.836298,"twenty":-6.043338,"median":-3.726587,"eighty":1.795307,"marketCap":8696776650},{"date":"2024-11-15","current":1.761541,"twenty":-6.022157,"median":-3.710504,"eighty":1.796132,"marketCap":8473335020},{"date":"2024-11-22","current":1.788782,"twenty":-5.980856,"median":-3.669625,"eighty":1.795452,"marketCap":8604365974},{"date":"2024-11-29","current":1.92347,"twenty":-5.959401,"median":-3.641728,"eighty":1.799135,"marketCap":9252241246},{"date":"2024-12-06","current":1.828129,"twenty":-5.955617,"median":-3.621995,"eighty":1.805651,"marketCap":8793632907},{"date":"2024-12-13","current":1.797862,"twenty":-5.950068,"median":-3.584982,"eighty":1.808349,"marketCap":8648042958},{"date":"2024-12-20","current":1.740355,"twenty":-5.940624,"median":-3.556632,"eighty":1.808807,"marketCap":8371422056},{"date":"2024-12-27","current":1.816022,"twenty":-5.937226,"median":-3.538361,"eighty":1.814437,"marketCap":8735396928},{"date":"2025-01-03","current":1.828129,"twenty":-5.937226,"median":-3.502516,"eighty":1.814437,"marketCap":8793632907},{"date":"2025-01-10","current":1.667714,"twenty":-5.936463,"median":-3.489823,"eighty":1.814437,"marketCap":8022006178},{"date":"2025-01-17","current":1.64804,"twenty":-5.931806,"median":-3.459421,"eighty":1.81012,"marketCap":7927372712},{"date":"2025-01-24","current":1.696467,"twenty":-5.919996,"median":-3.442407,"eighty":1.808689,"marketCap":8160316630},{"date":"2025-01-31","current":1.720681,"twenty":-5.911027,"median":-3.427114,"eighty":1.808297,"marketCap":8276788589},{"date":"2025-02-07","current":1.645013,"twenty":-5.893917,"median":-3.410632,"eighty":1.807254,"marketCap":7912813717},{"date":"2025-02-14","current":-63.938672,"twenty":-5.936654,"median":-3.427114,"eighty":1.806273,"marketCap":7456591836},{"date":"2025-02-21","current":-65.590676,"twenty":-5.950068,"median":-3.43596,"eighty":1.805651,"marketCap":7649250189},{"date":"2025-02-28","current":-63.510374,"twenty":-6.028354,"median":-3.459421,"eighty":1.804623,"marketCap":7406643374},{"date":"2025-03-07","current":-64.856452,"twenty":-6.095845,"median":-3.489823,"eighty":1.803146,"marketCap":7563624254},{"date":"2025-03-14","current":-63.755116,"twenty":-6.138729,"median":-3.504703,"eighty":1.801321,"marketCap":7435185352},{"date":"2025-03-21","current":-67.120309,"twenty":-6.224851,"median":-3.540051,"eighty":1.799375,"marketCap":7827637554},{"date":"2025-03-28","current":-64.122228,"twenty":-6.294119,"median":-3.568302,"eighty":1.797622,"marketCap":7477998319},{"date":"2025-04-04","current":-61.246517,"twenty":-6.57821,"median":-3.611042,"eighty":1.797217,"marketCap":7142630074},{"date":"2025-04-11","current":-59.043845,"twenty":-6.696468,"median":-3.629292,"eighty":1.796471,"marketCap":6885752269},{"date":"2025-04-17","current":-61.307702,"twenty":-7.029605,"median":-3.656118,"eighty":1.795452,"marketCap":7149765569}],"updateTime":1745134320062}}}